tirzepatide), or flag individuals who may need closer monitoring
Glucagon-like peptide 1 (GLP-1) receptor agonists, commonly referred to as GLP-1 drugs, are widely recognized for their use in managing type 2 diabetes and supporting weight loss
Trials on Zepbound found that 0.1% of patients had a severe hypersensitivity reaction (such as anaphylaxis) compared to 0% in the placebo group
Patients should feel confident and supported in their ability to manage weight and health without relying solely on medication
We asked nutritionists Some food companies, including Nestle and Conagra, are responding to the popularity of obesity and diabetes drugs by branding some products "GLP-1 Friendly." The labels target a growing number of consumers taking medicines such as Zepbound and Wegovy who may be looking for healthier, ready-made meals that minimize side-effects from the drugs
Direct-Pay GLP-1 Options Without Insurance Requirements PlexusDx provides compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan through licensed 503A compounding pharmacies, eliminating the need for insurance approval or employer coverage
